Skip to main content

Advertisement

Table 1 Patient characteristics

From: Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study

  Glycerol 200 mL/30 min Glycerol 200 mL/60 min Mannitol 300 mL/60 min P value
n = 13 n = 13 n = 7  
Age, years 57 (47–66) 46 (38–69) 58 (45–62) 0.592
Male, sex 6 (46.1%) 5 (38.5%) 4 (57.2%) 0.724
Height, cm 161 (154–166) 155 (154–164) 170 (155–170) 0.229
Body weight, kg 60 (51–65) 60 (55–69) 62 (54–67) 0.731
Body mass index, kg/m2 23.9 (19.4–25.7) 25.0 (21.2–26.9) 21.7 (21.1–27.9) 0.573
Diseases, %     0.426
Brain tumor 7.7% 23.1% 0.0%  
Intracranial hemorrhage 15.4% 23.1% 14.3%  
Sub-arachnoid hemorrhage 23.1% 7.7% 42.9%  
Cerebral infarction 38.5% 38.5% 28.6%  
Traumatic brain injury 0.0% 7.7% 14.3%  
Other 15.4% 0.0% 0.0%  
IHD 7.7% 0.0% 0.0% 0.452
CHF 0.0% 15.4% 0.0% 0.194
Atrial fibrillation 15.4% 15.4% 0.0% 0.542
Diabetes mellitus 15.4% 23.1% 14.3% 0.840
Hypertension 30.8% 23.1% 42.9% 0.655
APACHE II 19 (13–22) 16 (13–28) 18 (11–22) 0.858
28-day survival, % 69.2% 100.0% 100.0% 0.030
  1. APACHE II Acute Physiology and Chronic Health Evaluation II score, CHF chronic heart failure, IHD ischemic heart disease